H, Krause M, Eng J, Go ¨ke B: Exendin-4 isa high potency agonist and truncated ex-endin-(9–39)-amide an antagonist at theglucagon-like peptide 1-(7–36)-amide re-ceptor of insulin-secreting /H9252-cells. J Biol Chem 268:19650–19655, 1993 32. Szayna M, Doyle ME, Betkey JA, Hollo- way HW, Spencer RGS, Greig NH, EganJM: Exendin-4 decelerates food intake,weight gain, and fat deposition in Zuckerrats. Endocrinology 141:1936–1941, 2000 33. Gedulin BR, Nikoulina SE, Smith PA, Gedulin G, Nielsen LL, Baron AD, ParkesD, Young AA: Exenatide (exendin-4) im-proves insulin sensitivity and /H9252-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and bodyweight. Endocrinology. 146:2069–2076, 2005 34. Buse JB, Henry RR, Han J, Kim DD, Fine- man MS, Baron AD: Effects of exenatide(exendin-4) on glycemic control over 30weeks in sulfonylurea-treated patientswith type 2 diabetes mellitus. Diabetes Care 27:2628–2635, 2004 35. DeFronzo R, Ratner R, Han J, Kim D, Fine-